Small cell neuroendocrine carcinoma, also known as anaplastic small cell or oat cell carcinoma, is afrequ ently encountered bronchogenic neoplasm. Despite the fa ct that the embryologic origins ofthe larynx and the lung are the same, laryngeal manifestation of small cell neuroendocrine carcinoma is unusual, acco unting fo r less than 0.5% oflaryngeal carcinomas.I We present the case ofa 72-year-old man with small cell neuroendocrine carcinoma of the larynx, who was treated with f ull-co urse radiotherapy and achieved complete tumor remission. Subsequently, multiple liver metastases were confirmed and systemic chemotherapy was initiated. Unf ortunately, the pat ient died 12 months after initiation of tumordirected therapy.
month s after completion of radiotherapy , multiple liver meta stases were confirmed and systemic chemotherapy (Carboplatin and Etopos id) was administere d. Despite these efforts, the patient died 12 month s afte r the initiation of tumor-directed therapy .
Discussion
Small cell neuroendocrin e carcinoma of the laryn x is a rare carcinoma tha t is imp ortant to recogn ize; it has a more aggressive biologic beh avior and requires different treatment than the more comm on laryngeal neopl asms. It is a highly malignant neoplasm com pose d of round, oval or spindle cells with histochemi cal , immunohi stolo gical and ultrastructural evide nce of neuroendocrin e differenti ation . Three histolo gic categories can be distinguished : oat cell , .intermed iate and co mbined-c ell type.' Sm all cell neuro end ocrine carcin oma usually app ears in male smokers in the sixth or seve nth decades ofl ife. Clin icall y, these For more information, call or write:
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pati ents co mplain freq uently of hoarsen ess, dys pnea , and rapidly growing neck masses, Paraneoplastic syndromes may be assoc iated wi th the disease.
Any region of the laryn x can be affected, but the incidence is highest in the subglottic larynx. The tumors are frequently cov ered with intact mucosa.' Th e acco mpa nying figure clearly shows the typ ical laryngoscop ic appearance.
Approximately 50% of affected patie nts initially have cervical nodal metastasis; distant metastases are com mon in the liver, lung, bone and brain. Primary radiatio n therapy with adj uvant chemotherapy is the treatment of cho ice. Limited surgica l treatment may be con sid ered in select cases as a mu ltidiscip linary approach;' however, the pro gnosis is poor, and two-and five-yea r survival rates are 16% and 5%, respect ively.I :M~F~~~~R;. ·Fo°R~rt~~I;SC~IBi~~f~}1f~MATION. SEEPACKAG EINSERT.
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